Autophagy and urothelial carcinoma of the bladder: A review. [PDF]
, 2016 The incidence of urothelial carcinoma of the urinary bladder (bladder cancer) remains high. While other solid organ malignancies have seen significant improvement in morbidity and mortality, there has been little change in bladder cancer mortality in the
Chandrasekar, Thenappan +1 more
core +2 more sources
FGFR3 Destabilizes PD-L1 via NEDD4 to Control T-cell–Mediated Bladder Cancer Immune Surveillance
Cancer Research, 2021 NEDD4 links two important molecules associated with targeted therapy and immune surveillance, providing mechanistic rationale and preclinical support for immuno-targeted combination therapy for FGFR3-activated bladder cancer.
Weiqiang Jing +9 more
semanticscholar +1 more source
Overview of bladder heating technology: matching capabilities with clinical requirements. [PDF]
, 2016 Moderate temperature hyperthermia (40-45°C for 1 h) is emerging as an effective treatment to enhance best available chemotherapy strategies for bladder cancer.
Stauffer, Paul R., van Rhoon, Gerard C.
core +6 more sources
Designing a Pragmatic Intervention to Help Improve the Bladder Cancer Patient Experience
Inquiry: The Journal of Health Care Organization, Provision, and Financing, 2021 Bladder cancer (BC) is the 10 th most common malignancy worldwide and the patient experience is found to be worse than that for patients diagnosed with other cancer types.
Agustina Bessa +26 more
doaj +1 more source
Urothelial bladder carcinoma metastasizing to the eye: a systematic review and case report [PDF]
, 2019 The eye is a rare site for disseminated malignancies; nevertheless, several tumors may metastasize to ocular structures. Few cases of urothelial and bladder cancer with eye involvement have been described in the literature thus far.
Brunelli, Matteo +12 more
core +1 more source
Multiparametric MRI of the bladder: inter-observer agreement and accuracy with the Vesical Imaging-Reporting and Data System (VI-RADS) at a single reference center [PDF]
, 2019 Objectives: To evaluate accuracy and inter-observer variability using Vesical Imaging-Reporting and Data System (VI-RADS) for discrimination between non-muscle invasive bladder cancer (NMIBC) and muscle-invasive bladder cancer (MIBC).
Barchetti, Giovanni +11 more
core +1 more source
Epidemiology of Bladder Cancer
Medical Science, 2020 Based on the latest GLOBOCAN data, bladder cancer accounts for 3% of global cancer diagnoses and is especially prevalent in the developed world. In the United States, bladder cancer is the sixth most incident neoplasm.
Kalyan Saginala +5 more
semanticscholar +1 more source
FTO modifies the m6A level of MALAT and promotes bladder cancer progression
Clinical and Translational Medicine, 2021 Background Nearly a half million people around the world are diagnosed with bladder cancer each year, and an incomplete understanding of its pathogenicity and lack of efficient biomarkers having been discovered lead to poor clinical management of bladder
L. Tao +8 more
semanticscholar +1 more source
The call for a strategic framework to improve cancer literacy in Europe
Archives of Public Health, 2020 Background Health literacy is increasingly being recognized as a widespread public health challenge in Europe. This commentary explores the importance of health literacy amongst cancer patients (ie, cancer literacy) and examines how cancer literacy can ...
Kristine Sørensen +6 more
doaj +1 more source
Defining Priorities to Improve Patient Experience in Non-Muscle Invasive Bladder Cancer [PDF]
, 2018 Although approximately 75% of bladder cancers are non-muscle invasive (NMIBC) at diagnosis, most research tends to focus on invasive disease (e.g., experiences related to radical cystectomy and urinary diversion). There is a lack of studies on quality of
Bogaczyk, Tyler L. +4 more
core +2 more sources